Clinical Trial Update: Escalating Clopidogrel by Involving a Genetic Strategy - Thrombolysis In Myocardial Infarction 56 [Phase 2]

View source ↗

Summary

Phase 2 trial updating clopidogrel escalation using a genetic strategy in myocardial infarction patients undergoing percutaneous coronary intervention completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Percutaneous Coronary Intervention

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: The TIMI Study Group | Conditions: Myocardial Infarction, Percutaneous Coronary Intervention | Phase 2 | Status: COMPLETED | Results posted: 2019-11-15